DLEU2 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 4.660600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
4.503200E-01
Normal-vs-Stage2
4.752000E-01
Normal-vs-Stage3
2.928000E-01
Normal-vs-Stage4
4.239000E-01
Stage1-vs-Stage2
7.863200E-01
Stage1-vs-Stage3
6.692800E-01
Stage1-vs-Stage4
8.103600E-01
Stage2-vs-Stage3
4.695200E-01
Stage2-vs-Stage4
6.635800E-01
Stage3-vs-Stage4
8.272200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
4.753000E-01
Normal-vs-AfricanAmerican
4.098800E-01
Normal-vs-Asian
4.604600E-01
Caucasian-vs-AfricanAmerican
5.230600E-01
Caucasian-vs-Asian
8.387000E-01
AfricanAmerican-vs-Asian
5.410800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
4.587400E-01
Normal-vs-Female
4.806600E-01
Male-vs-Female
6.138400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
4.372200E-01
Normal-vs-Age(41-60Yrs)
4.684800E-01
Normal-vs-Age(61-80Yrs)
4.703000E-01
Normal-vs-Age(81-100Yrs)
4.613400E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
9.217600E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
9.331000E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
9.961800E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
9.648200E-01
Age(41-60Yrs)-vs-Age(81-100Yrs)
8.668000E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
8.775400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
4.553400E-01
Normal-vs-Daily Drinker
4.535400E-01
Normal-vs-Weekly Drinker
4.318600E-01
Normal-vs-Occasional Drinker
5.149400E-01
Normal-vs-Social Drinker
4.466600E-01
Non Drinker-vs-Daily Drinker
9.889000E-01
Non Drinker-vs-Weekly Drinker
7.721200E-01
Non Drinker-vs-Occasional Drinker
4.804200E-01
Non Drinker-vs-Social Drinker
9.071000E-01
Daily Drinker-vs-Weekly Drinker
7.517800E-01
Daily Drinker-vs-Occasional Drinker
4.138200E-01
Daily Drinker-vs-Social Drinker
9.053600E-01
Weekly Drinker-vs-Occasional Drinker
3.313800E-01
Weekly Drinker-vs-Social Drinker
8.653600E-01
Occasional Drinker-vs-Social Drinker
4.214000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
7.721800E-01
Normal-vs-Grade 2
7.652000E-01
Normal-vs-Grade 3
4.314800E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
2.179800E-01
Grade 1-vs-Grade 3
1.112430E-01
Grade 1-vs-Grade 4
7.721800E-01
Grade 2-vs-Grade 3
4.131800E-01
Grade 2-vs-Grade 4
7.652000E-01
Grade 3-vs-Grade 4
4.314800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
4.342600E-01
Normal-vs-NonDiabetic
4.674000E-01
Diabetic-vs-NonDiabetic
4.440200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
3.980600E-01
Normal-vs-NoPancreatitis
4.668600E-01
Pancreatitis-vs-NoPancreatitis
3.009000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
5.043000E-01
Normal-vs-N1
4.555400E-01
N0-vs-N1
3.164000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
5.739800E-01
Normal-vs-TP53-NonMutant
4.430800E-01
TP53-Mutant-vs-TP53-NonMutant
3.612300E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
